Thomas J An, Stephanie L McNamara, Ali Ardestani, Omar Zurkiya, Alexis Cahalane, Michael S Stecker, Yan Epelboym, Ezra Burch, Khanant Desai, Sanjeeva P Kalva
PURPOSE: Superior vena cava (SVC) syndrome is a constellation of symptoms that results from partial or complete SVC obstruction. Endovascular SVC stenting is an effective treatment for SVC syndrome with rapid clinical efficacy and low risk of complications. In this study, we assess the technical and clinical outcomes of a cohort of patients with SVC syndrome treated with the AbreTM self-expanding venous stent (Medtronic, Inc, Minneapolis, MN, USA). METHODS: An institutional database was used to retrospectively identify patients with SVC syndrome treated with AbreTM venous self-expanding stent placement between 2021-2023...
April 26, 2024: Vascular and Endovascular Surgery